Biomea Fusion, Inc. Increase (Decrease) in Accounts Payable
Biomea Fusion, Inc. (BMEA) reported Increase (Decrease) in Accounts Payable of $73.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Biomea Fusion, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.31M, a 352.80% decline year-over-year.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.38M.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$3.17M, a 178.83% decline year-over-year.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.83M, a 158.48% decline year-over-year.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$9.70M, a 259.33% decline from fiscal 2024.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for fiscal 2024 was $6.09M, a 137.63% increase from fiscal 2023.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for fiscal 2023 was $2.56M, a 13.45% decline from fiscal 2022.
- Biomea Fusion, Inc. increase (decrease) in accounts payable for fiscal 2022 was $2.96M, a 362.50% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $73.00K 10-Q · filed 2026-08-05 | -$3.10M derived: sum of 3 quarters · filed 2026-08-05 | -$4.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-11 | -$1.79M derived: sum of 2 quarters · filed 2026-05-11 | -$3.62M derived: sum of 3 quarters · filed 2026-05-11 | -$3.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$5.00M derived: sum of 2 quarters · filed 2026-03-24 | -$4.48M derived: sum of 3 quarters · filed 2026-08-05 | -$9.70M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.31M derived: sum of 2 quarters · filed 2026-08-05 | -$6.53M 10-Q · filed 2025-11-04 | -$2.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $517.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.70M 10-Q · filed 2026-08-05 | -$683.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$5.22M 10-Q · filed 2026-05-11 | -$1.20M derived: sum of 2 quarters · filed 2026-05-11 | $1.93M derived: sum of 3 quarters · filed 2026-05-11 | $3.04M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $7.15M derived: sum of 2 quarters · filed 2026-03-24 | $8.26M derived: sum of 3 quarters · filed 2026-03-24 | $6.09M 10-K · filed 2026-03-24 |
| 2024-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.24M derived: sum of 2 quarters · filed 2025-11-04 | $2.07M 10-Q · filed 2025-11-04 | $5.73M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.06M 10-Q · filed 2025-08-05 | $2.60M derived: sum of 3 quarters · filed 2026-03-24 | $1.67M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-03-31 | -$2.18M 10-Q · filed 2025-05-05 | $1.49M derived: sum of 2 quarters · filed 2026-03-24 | $549.00K derived: sum of 3 quarters · filed 2026-03-24 | -$279.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2023-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.73M derived: sum of 2 quarters · filed 2026-03-24 | $1.90M derived: sum of 3 quarters · filed 2026-03-24 | $2.56M 10-K · filed 2026-03-24 |
| 2023-09-30 | -$936.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$1.76M derived: sum of 2 quarters · filed 2024-10-29 | -$1.10M 10-Q · filed 2024-10-29 | $1.87M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$828.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$163.00K 10-Q · filed 2024-07-31 | $2.81M derived: sum of 3 quarters · filed 2025-03-31 | $1.72M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $665.00K 10-Q · filed 2024-05-02 | $3.64M derived: sum of 2 quarters · filed 2025-03-31 | $2.54M derived: sum of 3 quarters · filed 2025-03-31 | $2.43M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.88M derived: sum of 2 quarters · filed 2025-03-31 | $1.76M derived: sum of 3 quarters · filed 2025-03-31 | $2.96M 10-K · filed 2025-03-31 |
| 2022-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | -$1.21M derived: sum of 2 quarters · filed 2023-10-30 | -$13.00K 10-Q · filed 2023-10-30 | $208.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $1.08M 10-Q · filed 2023-07-31 | $1.30M derived: sum of 3 quarters · filed 2024-03-28 | $1.48M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $1.20M 10-Q · filed 2023-05-02 | $1.42M derived: sum of 2 quarters · filed 2024-03-28 | $1.60M derived: sum of 3 quarters · filed 2024-03-28 | $1.79M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $403.00K derived: sum of 2 quarters · filed 2024-03-28 | $599.00K derived: sum of 3 quarters · filed 2024-03-28 | $640.00K 10-K · filed 2024-03-28 |
| 2021-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $378.00K derived: sum of 2 quarters · filed 2022-11-07 | $419.00K 10-Q · filed 2022-11-07 | $719.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $237.00K 10-Q · filed 2022-08-01 | $537.00K derived: sum of 3 quarters · filed 2023-03-28 | $583.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $41.00K 10-Q · filed 2022-05-16 | $341.00K derived: sum of 2 quarters · filed 2023-03-28 | $387.00K derived: sum of 3 quarters · filed 2023-03-28 | $389.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $346.00K derived: sum of 2 quarters · filed 2023-03-28 | $348.00K derived: sum of 3 quarters · filed 2023-03-28 | $418.00K 10-K · filed 2023-03-28 |
| 2020-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $48.00K derived: sum of 2 quarters · filed 2021-11-03 | $118.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $72.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $70.00K 10-Q · filed 2021-05-27 | |||
| 2019-12-31 | -$98.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |